NUCLEAR MEDICINE COMMUNICATIONS, cilt.32, sa.12, ss.1216-1222, 2011 (SCI-Expanded)
Objective Lymphoscintigraphy (LS) and sentinel lymph node biopsy have become the standard of care for melanoma and breast cancer. However, the data on patients with cutaneous squamous cell carcinoma (SCC) are limited. We aimed to evaluate and identify the role of LS and sentinel lymph node biopsy in patients with high-risk cutaneous SCC.